Skip to main content
Clinical Trials/NL-OMON51500
NL-OMON51500
Recruiting
Not Applicable

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT-2 trial). - ROBOT-2

niversity Medical Center Mainz0 sites109 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
niversity Medical Center Mainz
Enrollment
109
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
niversity Medical Center Mainz

Eligibility Criteria

Inclusion Criteria

  • \- Histologically proven squamous cell carcinoma, adenocarcinoma or
  • undifferentiated carcinoma of the intrathoracic esophagus (including Siewert I
  • \- Surgically resectable (T1\-4a, N0\-3, M0\)
  • \- Age \>\= 18 and \<\= 90 years
  • \- European Clinical Oncology Group (ECOG) performance status 0,1 or 2
  • \- Written informed consent

Exclusion Criteria

  • \- Carcinoma of the cervical esophagus
  • \- Carcinoma of the gastro\-esophageal junction (GEJ) with the main part of the
  • tumor in the gastric cardia (Siewert type III)
  • \- Prior thoracic surgery at the right hemithorax or thoracic trauma

Outcomes

Primary Outcomes

Not specified

Similar Trials